Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD40L (clone 5LC8P). We employs the Lentivirus (CMV-mCherry-TFIIA-NotI) vector components and the SynExpress system of the Single base pair Knock-in/Negative feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CD40L
Clone
5LC8P
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
mCherry
Promoter
CMV
Effector Gene
TFIIA
Insertion Sites
NotI
Gene Modification
Knock-in
Modification Domain
Single base pair
Carrier Type
Lentivirus
Transformation Accuracy
0.94
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.